Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MPC Injection in LVAD Patients
NCT01442129Phase 2Completed
- Start
- Apr 2012
- Primary completion
- Mar 2013
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of rexlemestrocel-l in heart failure (HF). Started Apr 2012; status: completed.
02
Drugs
rexlemestrocel-l
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT01442129.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01442129.